Santarus, Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention & treatment of gastrointestinal diseases and disorders.
| NASDAQ: SNTS |
| Current Price: 2.75 |
| Change: -0.10 |
7/3/2009 7:57:09 PM EST
Quotes delayed 20 minutes.
|
|
June 26, 2009
Santarus Joins the Russell 3000 Index
June 23, 2009
Santarus Announces December 2009 Action Date for Schering-Plough''s OTC ZEGERID New Drug Application
June 9, 2009
Santarus Announces Schering-Plough Response Submission to FDA for OTC ZEGERID
|
Santarus is hiring skilled people like you. Join our team today!
